NTHRYS › Projects › Molecular Endocrinology › Adrenal & Pituitary Molecular Disease Platforms › Primary Aldosteronism Genetic Screening Platform Solution

Primary Aldosteronism Genetic Screening Platform Solution

Molecular Endocrinology

Adrenal & Pituitary Molecular Disease Platforms

Variant

Pay · Join

Step 4 of 5Select variant

Field

▾

Category

▾

Focused area

▾

You might prefer

Real-time Cortisol Monitoring SaaS Dashboard Platform ACTH-Cortisol Biomarker Assay Kit Commercial Service HPA Axis Dysfunction Prediction Engine Software Tool TSH and Thyroid-Stimulating Hormone Mutation Database Automated Dexamethasone Suppression Test Interpretation AI Pituitary Adenoma Molecular Profiling Commercial Test Glucocorticoid Receptor Sensitivity Biomarker Testing Service Pituitary Hormone Secretion Pattern Analytics Cloud Platform Adrenal Steroidogenic Enzyme Mutation Interpretation Software

Molecular Endocrinology › Adrenal & Pituitary Molecular Disease Platforms

Primary Aldosteronism Genetic Screening Platform Solution

A comprehensive genetic screening and clinical phenotyping platform targeting KCNJ5, ATP1A1, and CACNA1D mutations in patients with resistant hypertension to enable precision treatment selection. Drives revenue through diagnostic test billings, integration partnerships with hospital networks, and pharmaceutical licensing for treatment matching algorithms.

Project Types — tap to learn more

Mode — tap to learn more

Duration — tap to learn more

Select your preferenceChoose Type, Mode, Duration to view Titles

Project Type

Mode

Duration

🎯

Choose your preferences above

Select Type, Mode and Duration to view available project variants and fees.